ArticleNeurology and therapy2022

Opicapone as an Add-on to Levodopa in Patients with Parkinson's Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial.

Joaquim J Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.